Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on St. Vincent & Grenadines Business Hub.
Press releases published on April 1, 2025
Vocodia Holdings Corp. Issues CEO Letter and Discusses Outlook for 2025
GlobeNewswire
·
April 1, 2025
BOCA RATON, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- Vocodia Holdings Corp. (OTC: VHAI) ("Vocodia"), a leader in AI software development focusing on practical AI applications, announced today that Brian Podolak, Co-founder, Chairman and CEO, has issued a …
Cannabix Technologies to Attend U.S. National Drug and Alcohol Conference to Market Marijuana Breath Test
GlobeNewswire
·
April 1, 2025
VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices is pleased to report that it will …
CEA Industries Inc. Provides Update on Acquisition of Leading Canadian Vape Retailer and Manufacturer, Fat Panda Ltd.
GlobeNewswire
·
April 1, 2025
Louisville, Colorado, April 01, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (NASDAQ: CEAD, CEADW) (“CEA Industries” or the “Company”), is providing an update on its previously announced acquisition of Fat Panda Ltd. (“Fat Panda”), a leading central …
Nightfood Acquires Skytech to Expand Leadership in AI-Driven Hotel Automation
GlobeNewswire
·
April 1, 2025
TARRYTOWN, NY, April 01, 2025 (GLOBE NEWSWIRE) -- via IBN -- Nightfood Holdings, Inc. (OTCQB: NGTF) (the “Company”), a leading innovator in hospitality automation through robotics and strategic property acquisition, today announces the successful …
FDCTech Reports Over 111% Revenue Growth in Fiscal Year 2024, Driven by Full-Year Contributions from Strategic Acquisitions
GlobeNewswire
·
April 1, 2025
Robust Revenue Expansion Across All Business Segments – Investment and Brokerage, Wealth Management, and Technology Solution. Irvine, CA, April 01, 2025 (GLOBE NEWSWIRE) -- FDCTech, Inc. ("FDC" or the "Company," PINK: FDCT), a fintech-driven firm …
Moleculin Doses First Patient in Pivotal, Adaptive Phase 3 MIRACLE Trial
GlobeNewswire
·
April 1, 2025
– Initial data readout on track for second half of 2025 HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates …
10 Winners Awarded “Justies” at Cellebrite’s First-Ever Digital Justice Awards
GlobeNewswire
·
April 1, 2025
TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 01, 2025 (GLOBE NEWSWIRE) -- Cellebrite (Nasdaq: CLBT), a global leader in Digital Investigative (DI) solutions for the public and private sectors, awarded ten winners “Justies” at the Company’s inaugural …
Aptose Common Shares to Delist from Nasdaq as of April 2, 2025
GlobeNewswire
·
April 1, 2025
SAN DIEGO and TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX:APS), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat …
Minnesota Twins, Fox 9 and Gray Media Announce 10-game, Free Over-the-air Television Package
GlobeNewswire
·
April 1, 2025
Twins return to over-the-air TV for first time since 2012 with 10 Tuesday games on FOX 9; 10 Gray Media stations ensure first outer market Twins Territory OTA coverage since 1988 ATLANTA, April 01, 2025 (GLOBE NEWSWIRE) -- Bringing Minnesota Twins baseball …
Safe Harbor Financial Reports Fourth Quarter and Year-End 2024 Results
GlobeNewswire
·
April 1, 2025
— Adjusted EBITDA(1) is positive for each of the last 3 years; Adjusted Working Capital(2) is approximately positive $2 million — Loan Interest Income increased 82% and 123% year-over-year for the three months and full-year ended December 31, 2024, …
Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment
GlobeNewswire
·
April 1, 2025
The clinical trial is designed to evaluate the safety, tolerability and efficacy of Clearmind’s innovative, psychedelic-derived, MEAI-based compound in individuals with alcohol addiction Vancouver, Canada, April 01, 2025 (GLOBE NEWSWIRE) -- Clearmind …
Guardforce AI Launches DVGO, an AI Travel Planning Tool Powered by Specialized AI Agents, in the United States
GlobeNewswire
·
April 1, 2025
NEW YORK, NY , April 01, 2025 (GLOBE NEWSWIRE) -- Guardforce AI Co., Limited (“Guardforce AI” or the “Company”) (NASDAQ: GFAI, GFAIW), a global integrated security provider specializing in secured logistics, Artificial Intelligence (AI), and Robot-as-a- …
Super Micro Computer Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation
GlobeNewswire
·
April 1, 2025
SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of Super Micro Computer, Inc. (NASDAQ: SMCI) against certain of its officers and directors to hold them responsible for damages they allegedly …
Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations
GlobeNewswire
·
April 1, 2025
PARSIPPANY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced a new landmark publication in the Mayo Clinic Proceedings. The …
Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
April 1, 2025
Lab network revenue increased by 33% year over year, reflecting strong demand for ColoAlert® in EuropeOperating loss decreased by 30% and net loss by 18%, driven by targeted cost reductions and a sharper strategic focusBERKELEY, Calif. and MAINZ, Germany, …
Nkarta to Participate in an April Investor Conference
GlobeNewswire
·
April 1, 2025
SOUTH SAN FRANCISCO, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conference: 24th …
Mersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual Congress
GlobeNewswire
·
April 1, 2025
CAMBRIDGE, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of …
Phathom Pharmaceuticals Announces Leadership Succession
GlobeNewswire
·
April 1, 2025
FLORHAM PARK, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that Steven …
Coherus Announces Repurchase of Approximately $170 Million of Convertible Notes
GlobeNewswire
·
April 1, 2025
– Remaining $60 Million of outstanding convertible notes to be repurchased post-close of pending UDENYCA divestiture – REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company,” NASDAQ: CHRS) announced …
Occidental Announces Results of Offer to Exercise Warrants at a Temporarily Reduced Price
GlobeNewswire
·
April 1, 2025
HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Occidental (NYSE: OXY) today announced the results of its offer to exercise Occidental’s outstanding publicly traded warrants (the “Warrants”) at a temporarily reduced price of $21.30 per Warrant (the “Offer”). …